Literature DB >> 14969745

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma.

Adrian J Frank1, Roberto Hernan, Andrew Hollander, Janet C Lindsey, Meryl E Lusher, Christine E Fuller, Steven C Clifford, Richard J Gilbertson.   

Abstract

We analyzed the TP53 and INK4A/ARF loci in 29 pediatric medulloblastomas. Mutually exclusive mutation in TP53, methylation of P14(ARF) or deletion of INK4A/ARF were identified in 21% (6/29) of tumors. Five of these alterations were detected in large cell/anaplastic medulloblastomas or tumors with significant anaplasia. Our data provide the first evidence that alterations within the TP53-ARF tumor suppressor pathway contribute to development of aggressive forms of medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14969745     DOI: 10.1016/j.molbrainres.2003.11.016

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  25 in total

Review 1.  Matching mice to malignancy: molecular subgroups and models of medulloblastoma.

Authors:  Jasmine Lau; Christin Schmidt; Shirley L Markant; Michael D Taylor; Robert J Wechsler-Reya; William A Weiss
Journal:  Childs Nerv Syst       Date:  2012-04       Impact factor: 1.475

2.  HDM2 promotes WIP1-mediated medulloblastoma growth.

Authors:  Meghan C Buss; Tracy-Ann Read; Matthew J Schniederjan; Khanjan Gandhi; Robert C Castellino
Journal:  Neuro Oncol       Date:  2012-02-29       Impact factor: 12.300

3.  DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.

Authors:  Allison R Hanaford; Tenley C Archer; Antoinette Price; Ulf D Kahlert; Jarek Maciaczyk; Guido Nikkhah; Jong Wook Kim; Tobias Ehrenberger; Paul A Clemons; Vlado Dančík; Brinton Seashore-Ludlow; Vasanthi Viswanathan; Michelle L Stewart; Matthew G Rees; Alykhan Shamji; Stuart Schreiber; Ernest Fraenkel; Scott L Pomeroy; Jill P Mesirov; Pablo Tamayo; Charles G Eberhart; Eric H Raabe
Journal:  Clin Cancer Res       Date:  2016-03-24       Impact factor: 12.531

4.  WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.

Authors:  Tiffany A Doucette; Yuhui Yang; Carolyn Pedone; John Y H Kim; Adrian Dubuc; Paul D Northcott; Michael D Taylor; Daniel W Fults; Ganesh Rao
Journal:  Neurosurgery       Date:  2012-04       Impact factor: 4.654

5.  An animal model of MYC-driven medulloblastoma.

Authors:  Yanxin Pei; Colin E Moore; Jun Wang; Alok K Tewari; Alexey Eroshkin; Yoon-Jae Cho; Hendrik Witt; Andrey Korshunov; Tracy-Ann Read; Julia L Sun; Earlene M Schmitt; C Ryan Miller; Anne F Buckley; Roger E McLendon; Thomas F Westbrook; Paul A Northcott; Michael D Taylor; Stefan M Pfister; Phillip G Febbo; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

6.  A mouse model of the most aggressive subgroup of human medulloblastoma.

Authors:  Daisuke Kawauchi; Giles Robinson; Tamar Uziel; Paul Gibson; Jerold Rehg; Cuilan Gao; David Finkelstein; Chunxu Qu; Stanley Pounds; David W Ellison; Richard J Gilbertson; Martine F Roussel
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

7.  BRCA2 is required for neurogenesis and suppression of medulloblastoma.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Jayne Lamont; Peter J McKinnon
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

8.  Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  Stephen Qualman; James Lynch; Julia Bridge; David Parham; Lisa Teot; William Meyer; Alberto Pappo
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

9.  Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin?

Authors:  Roberta Salaroli; Tiziano Di Tomaso; Alice Ronchi; Claudio Ceccarelli; Silvia Cammelli; Alessandra Cappellini; Giuseppe Nicola Martinelli; Enza Barbieri; Felice Giangaspero; Giovanna Cenacchi
Journal:  J Neurooncol       Date:  2008-08-08       Impact factor: 4.130

10.  Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.

Authors:  Yuan Lu; Sarra L Ryan; David J Elliott; Graham R Bignell; P Andrew Futreal; David W Ellison; Simon Bailey; Steven C Clifford
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.